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Molecular and conventional epidemiologic techniques were used to study the mechanisms and risk factors
for tuberculosis transmission in a rural area with high prevalence in south India. Restriction fragment length
polymorphism analysis with IS6110 and direct repeat probes was performed with 378 Mycobacterium tubercu-
losis isolates from patients. Forty-one percent of M. tuberculosis isolates harbored a single copy of IS6110. Of
378 patients, 236 had distinct strains; 142 (38%) shared a strain with other patients, indicating recent
infection. Older patients, those detected by a house-to-house community survey, and those hospitalized in a
sanatorium were more likely to have had a recent infection. These findings suggest that the majority of the
tuberculosis cases in south India were due to reactivation; therefore, efforts to control tuberculosis should be
sustained.
Each year, nearly 3.5 million new cases of infectious tuber-
culosis (TB) occur worldwide (11). Molecular epidemiologic
studies of Mycobacterium tuberculosis strains by using DNA
fingerprinting have provided valuable information about the
mechanisms of transmission of TB. Most of these studies,
however, have been conducted in countries with a low inci-
dence of tuberculosis and usually in urban settings with pockets
of high transmission. In such settings, 35 to 50% of new TB
cases are the result of recent person-to-person or exogenous
transmission (1, 12, 25). Few molecular epidemiologic studies
have been conducted in countries with a high incidence of TB
(10, 16).
India has the highest number of incident TB cases in the
world. The limited numbers of molecular epidemiologic stud-
ies conducted in India were laboratory based and comprised
small numbers of patients (9, 24). Risk factors for exogenous
transmission of TB have not been documented in the country.
This study combined molecular and conventional epidemio-
logic techniques to investigate the mechanisms and risk factors
for TB transmission in a rural area of high prevalence in south
India.
The study site was Tiruvallur District, where the world’s
largest Mycobacterium bovis BCG trial was conducted (28).
The total population of the study area is 580,000. The inci-
dence of smear-positive TB is 76 per 100,000 in the population
(29). The study subjects were all TB patients undergoing treat-
ment according to the Revised National Tuberculosis Control
Program guidelines (21) at one of the 17 primary health cen-
ters in the study area from July 1999 to June 2000. Within a
week of commencing treatment, two sputum samples were
collected from each patient for mycobacterial culture on Lo-
wenstein-Jensen (LJ) medium. The samples that yielded pos-
itive cultures were further confirmed to be typical M. tubercu-
losis strains (2) and tested for drug susceptibility. The DNA
extraction and restriction fragment length polymorphism
(RFLP) analysis were performed by standard protocols (9, 18,
24, 30). Two investigators independently analyzed the patterns
by visual inspection. For quality control, RFLP was repeated
with an additional specimen for 75 patients (20%). The RFLP
patterns were identical in both specimens of each of the 75
patients; hence, only one specimen from each patient was
included for further analysis. Standard definitions were used to
classify patients according to the type and category of TB (33).
Patients who demonstrated identical RFLP patterns by IS6110
and direct repeat (DR) probes were considered to belong to
the same cluster. Patients in a cluster were interviewed to
investigate epidemiologic linkages. Patients were considered
epidemiologically linked if they reported acquaintance with
one or more patients in the same cluster. Data were analyzed
with Epiinfo version 6.04 (Centers for Disease Control and
Prevention, Atlanta, Ga.). Chi-square and Fisher exact tests
were used to interpret univariate analyses.
Of 437 culture-positive patients treated during the study
period, isolates from 378 were available for RFLP analysis.
Characteristics of patients for whom RFLP data were unavail-
able (n 59) were similar to those of patients for whom RFLP
data were available (n  378), but the former were more likely
to have multidrug-resistant (MDR) TB (10% versus 2%; P 
0.03). Fifty-seven of the 378 (15%) patients included in the
analysis could not be interviewed to investigate epidemiologic
linkages.
RFLP analysis by IS6110 identified 4 strains (1%) with no
copy, 154 strains (41%) with one copy, 99 strains (26%) with 2
to 5 copies, and 121 strains (32%) with 6 copies. Of the 378
patients, 225 (60%) carried strains shared by at least 1 other
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patient. These 225 patients were in 17 clusters; the largest
cluster contained 142 patients, whose DNA fingerprints dis-
played a common characteristic single band. Overall, RFLP by
IS6110 identified 271 distinct patterns among 378 isolates.
Combined RFLP analysis with IS6110 and the DR probes
identified 236 patients with distinct patterns, and 142 patients
(38%) carried a strain shared with at least one other patient.
These 142 patients were in one of the 35 clusters (Table 1 and
Fig. 1). The number of patients in each cluster ranged from 2
to 25. Excluding 78 patients who had a single copy of IS6110,
there were 34 patients (9%) who had a clustered isolate by
both probes.
Patients who had been identified by house-to-house survey
were more likely to be part of a cluster than those who had
been identified when they sought care at a health facility (49%
versus 35%; P  0.06). Patients who had a relapse were insig-
nificantly more likely to be part of a cluster compared with new
patients (10 of 18, 56%, versus 114 of 302, 38%; P 0.2). Eight
of the 10 patients with relapse who were in a cluster had
isolates with a single band. Patients who had been hospitalized
in a sanatorium were somewhat more likely to be in a cluster
than those who had not been (47% versus 34%; P  0.06).
MDR, alcoholism, family size, and close contact with a pulmo-
nary TB patient were not significant risk factors for clustering.
Limiting the analysis to patients detected by house-to-house
survey (n  66) showed that patients in a cluster were signif-
icantly older than patients who were not (55 versus 43 years; P
 0.01).
One hundred thirty-one of the 142 patients who were in one
or more clusters could be contacted for epidemiologic investi-
gation. Of these 131 patients, 21 (16%) reported acquaintance
with one or more patients in the same cluster. Eleven of the 35
clusters comprised four or more patients, and these were an-
alyzed in detail (Table 2). In clusters 2 and 7, clustering was
significantly associated with case detection by a house-to-house
community survey. Being hospitalized in a sanatorium was a
significant risk factor for clustering among patients in cluster
10.
This investigation reports several characteristics of the mo-
lecular epidemiology of TB, by using IS6110 and DR probes,
which differ from previously reported findings in other settings.
Forty-one percent of M. tuberculosis isolates harbored a single
IS6110 copy. Such a high proportion of single-copy isolates has
not been reported elsewhere except in south India (9, 24; I.
Radhakrishnan, Y. K. Manju, R. Ajaykumar, and S. Mun-
dayoor, Letter, J. Clin. Microbiol. 39:1683, 2001). Other than
studies in South East Asian countries, which have reported
single-copy strain prevalences of up to 20% (13, 22, 34), most
studies have reported less than 5% single-copy strains (5, 16,
19, 20). Not all IS6110 single-copy isolates are genetically iden-
tical or clonal in origin (18). In this study, a third of the IS6110
single-copy clusters were differentiated by the DR probe.
The proportion of clustering in this study ranged from 9 to
38%, depending on whether single-copy strains were excluded
FIG. 1. DR RFLP patterns associated with a clustered M. tuberculosis isolate in Tiruvallur District, South India, July 1999 to June 2000. STD,
standard.
TABLE 1. IS6110 and DR RFLP patterns among 142 TB patients
in a cluster in Tiruvallur, South India, July 1999 to June 2000
Lane no.
Pattern (no. of bands) No. of patients
in clusterIS6110 probe DR probe
1 No copy B041 (4) 2
2 A (1) B001 (4) 2
3 A (1) B002 (5) 25
4 A (1) B003 (5) 6
5 A (1) B039 (5) 7
6 A (1) B058 (5) 2
7 A (1) B007 (6) 2
8 A (1) B010 (6) 10
9 A (1) B014 (6) 5
10 A (1) B018 (6) 4
11 A (1) B027 (6) 6
12 A (1) B038 (6) 3
13 A (1) B046 (6) 2
14 A (1) B054 (6) 2
15 A (1) B009 (7) 3
16 A (1) B032 (7) 8
17 A (1) B036 (7) 5
18 A (1) B043 (7) 2
19 A (1) B077 (7) 3
20 A (1) B088 (7) 7
21 E (2) B014 (6) 3
22 H (2) B071 (4) 2
23 H (2) B119 (6) 2
24 M (2) B014 (6) 2
25 E (3) B014 (6) 2
26 N (3) B032 (7) 2
27 B (4) B002 (5) 4
28 B (4) B027 (6) 2
29 C (4) B002 (5) 2
30 H (4) B002 (5) 2
31 D (5) B002 (5) 3
32 F (5) B002 (5) 3
33 G (5) B002 (5) 2
34 P (5) B002 (5) 2
35 A (7) B002 (5) 3
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or included in the analysis, respectively. The proportion of
recently transmitted cases is reported to vary widely from 10%
to 58% (3, 4, 7, 8, 10, 15, 17, 20, 25, 26) in developed countries
and from 20% to 36% in developing countries (12, 16, 32). In
addition to the relatively low clustering, the transmission pat-
tern may also differ in our setting. In investigations conducted
in industrialized countries, an index case was often identified
and transmission links could be established among most of the
patients in clusters (1, 25). Despite the intensive field investi-
gations in this study, definite epidemiological links were iden-
tified in less than a fifth of the patients who shared similar
strains. Even in the largest cluster, comprising 25 patients, links
could be established only between pairs. These findings suggest
that several people exposed to a small risk may account for
more cases than a few people exposed to a high risk (23). It is
likely that the patients in this study were infected at crowded
places, such as bus stops, railway stations, cinemas, and out-
patient health facilities or during religious festivals.
Another important observation of this study is that cluster-
ing was higher among older patients. Most other studies have
reported recent transmission in the younger age groups (14, 26,
32). It is commonly believed that transmission due to endog-
enous reactivation increases with age. In this study setting,
there are at least two likely explanations for the higher clus-
tering among older patients. First, there are certain strains
endemic to the region and therefore available for transmission
over a considerable period of time among residents living in
neighboring communities for several years. Ninety percent of
the patients in this study lived in the same place for more than
5 years. Second, the source of infection could be a reactivated
strain from an older patient, which could subsequently have
been recently transmitted to individuals belonging to one age
group, because of peer interaction and crowded living condi-
tions. The same reasons could also account for the higher
percentage of clustering attributable to the door-to-door sur-
vey carried out with 17% of the population in this study.
A higher proportion of clustering was observed among pa-
tients who had a relapse. Furthermore, a majority of the pa-
tients who had a relapse and were in a cluster harbored an
IS6110 single-copy strain. Nearly half the patients who gave a
history of hospitalization in a TB sanatorium in the past 5 years
were in a cluster. While epidemiologic links among these pa-
tients could not be identified, nosocomial transmission may be
a likely cause, as has been reported elsewhere (14).
Previous studies have reported higher clustering among
drug-resistant patients than drug-sensitive ones (1, 6, 14, 26,
27). We found no association between drug resistance and
clustering. However, the rate of MDR TB was higher among
patients in whom RFLP patterns were not available; there may
thus be a bias causing the possible underestimation of the
proportion of MDR TB patients who were in clusters.
In conclusion, the findings of this study suggest that the
majority of the TB cases in south India occur predominantly
due to reactivation. With the large-scale introduction of di-
rectly observed treatment—short course (DOTS) in 1998, the
transmission of infection is likely to be reduced due to the
higher cure and lower relapse rates. However, the reactivation
of latent infection will continue to perpetuate new cases for
years to come despite effective DOTS implementation. There-
fore, DOTS implementation in India must be supplemented by
intensive and early case detection of TB, infection control
measures to prevent TB transmission at outpatient and inpa-
tient health facilities, and community education. Long-term
strategies such as developing prophylactic tools capable of
preventing infection and progression to disease should also be
undertaken. Similar studies are required to characterize the
molecular epidemiology of M. tuberculosis in other regions of
India and to learn whether the high percentage of IS6110
single-copy strains identified in this study is unique to south
India. Further research is needed to understand the role of
virulence in reactivation of M. tuberculosis strains.
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TABLE 2. Characteristics of patients with unique RFLP patterns and patients in 11 clusters of 4 patients in Tiruvallur District, South India,
July 1999 to June 2000a
Cluster No. ofpatients
No. of bands
Median
age (yr)
% of patients
IS6110 DR Epidemiologicallylinked Age 45 yr Men Alcoholic Employed MDR
Diagnosed
by survey
Hospitalized
in a
sanatorium
Distinct RFLP 236 42 48 84 33 77 4 14 16
1 25 1 5 45 27 56 76 55 64 4 20 25
2 6 1 5 49 0 67 100 40 100 17 50* 0
3 7 1 5 45 2 57 86 60 100 0 14 29
4 10 1 5 49 22 70 80 33 67 14 10 40
5 5 1 6 35 0 20 80 0 80 0 40 20
6 4 1 6 31 0 100 100 25 100 25 0 0
7 6 1 6 43 0 67 83 33 83 0 67† 0
8 8 1 7 50 0 75 75 17 83 0 38 13
9 5 1 7 40 0 40 60 0 75 0 20 20
10 7 1 7 50 0 71 86 29 43 0 14 57*
11 4 4 5 44 0 50 100 33 100 0 0 0
a P values are noted for comparison with characteristics of patients with unique RFLP patterns: *, P  0.05; †, P  0.01.
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